16 January 2018
News and Views
Links and Services
Mesalazine improves quality of life in ulcerative colitis
The most recent issue of Alimentary Pharmacology & Therapeutics evaluates the effect of mesalazine therapy on quality of life in patients with active ulcerative colitis.
Ulcerative colitis has a major impact on the quality of life of affected patients.
Aliment Pharmacol Ther 2008: 28(11-12): 1278-86
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors